Reported about 12 hours ago
Walgreens shares dropped over 5% as analysts expressed skepticism about the feasibility of a potential sale, stating the stock price had 'run too far' on speculation. Deutsche Bank cut its price target to $9, suggesting the shares may not be valued at or above their current levels. The report indicates that while Walgreens shares had risen following news of a sale exploration, challenges in retail pharmacy fundamentals and ongoing investigations could hinder the company's prospects.
Source: YAHOO